Scarica l'app Stockscreener
10.05
2.43%
-0.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PRTA Giù?
Forum
Previsione
Precedente Chiudi:
$10.30
Aprire:
$10.34
Volume 24 ore:
733.91K
Relative Volume:
0.81
Capitalizzazione di mercato:
$540.99M
Reddito:
$217.25M
Utile/perdita netta:
$-50.92M
Rapporto P/E:
-10.05
EPS:
-1
Flusso di cassa netto:
$-100.85M
1 W Prestazione:
+1.31%
1M Prestazione:
+21.01%
6M Prestazione:
+3.72%
1 anno Prestazione:
-40.11%
Intervallo 1D:
$9.98
$10.45
Intervallo di 1 settimana:
$9.77
$10.65
Portata 52W:
$4.32
$18.88
Prothena Corporation Plc Stock (PRTA) Company Profile
Nome
Prothena Corporation Plc
Settore
Industria
Telefono
011-353-1-236-2500
Indirizzo
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Confronta PRTA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
10.05 | 554.45M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-28 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-27 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Iniziato | Chardan Capital Markets | Buy |
| 2024-01-30 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-04-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-27 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-06-18 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Reiterato | Oppenheimer | Outperform |
| 2021-05-26 | Iniziato | Citigroup | Buy |
| 2021-02-26 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-02-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-07 | Iniziato | H.C. Wainwright | Buy |
| 2020-07-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Downgrade | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Downgrade | Jefferies | Buy → Hold |
| 2018-04-05 | Reiterato | Barclays | Overweight |
| 2017-11-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2017-09-29 | Reiterato | BTIG Research | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Jefferies | Buy |
| 2017-04-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2017-03-02 | Iniziato | Instinet | Buy |
| 2016-12-21 | Iniziato | SunTrust | Buy |
| 2016-11-03 | Iniziato | Deutsche Bank | Buy |
| 2016-08-04 | Reiterato | Barclays | Overweight |
| 2016-05-13 | Iniziato | Barclays | Overweight |
| 2016-02-19 | Reiterato | Wedbush | Outperform |
| 2016-01-21 | Iniziato | Credit Suisse | Outperform |
Mostra tutto
Prothena Corporation Plc Borsa (PRTA) Ultime notizie
Tools to monitor Prothena Corporation plc recovery probabilityOptions Play & Long-Term Capital Growth Ideas - newser.com
Why Prothena Corporation plc stock is seen as undervaluedMarket Performance Report & Daily Stock Momentum Reports - newser.com
FY2029 EPS Estimates for Prothena Boosted by HC Wainwright - MarketBeat
Prothena Corporation plc stock volume spike explained2025 Top Decliners & Community Consensus Trade Signals - newser.com
What data driven models say about Prothena Corporation plc’s futureMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
What analysts say about Prothena Corporation plc stockAnalyst Downgrades & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
Prothena stock price target raised to $20 from $14 at H.C. Wainwright - Investing.com Nigeria
Prothena Corp. Experiences Revision in Stock Evaluation Amid Market Challenges - Markets Mojo
Public Employees Retirement System of Ohio Invests $256,000 in Prothena Corporation plc $PRTA - Defense World
Prothena Corp (PRTA) Sees Raised Price Target by HC Wainwright & Co. | PRTA Stock News - GuruFocus
Is now a turning point for Prothena Corporation plcBull Run & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-10-05 07:33:52 - newser.com
Leading vs lagging indicators on Prothena Corporation plc performance2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Evaluating Prothena Corporation plc with trendline analysisWeekly Trade Review & Daily Profit Maximizing Tips - newser.com
Published on: 2025-10-03 05:55:14 - newser.com
How moving averages guide Prothena Corporation plc tradingJuly 2025 Summary & Free Technical Confirmation Trade Alerts - newser.com
Prothena Corporation plc (NASDAQ:PRTA) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986 - PharmiWeb.com
Prothena's partner Bristol Myers Squibb obtains fast track designation from US FDA for BMS-986446 for treatment of Alzheimer's disease - MarketScreener
Prothena’s Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 (PRX005), an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer’s Disease - Business Wire
Hopeful Week For Insiders Who Bought US$2.75m Of Prothena Stock - 富途牛牛
Published on: 2025-09-30 03:25:21 - newser.com
Published on: 2025-09-29 17:23:52 - newser.com
Prothena Corporation Plc Azioni (PRTA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Prothena Corporation Plc Azioni (PRTA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
| SCULLY WILLIAM P | 10% Owner |
Jan 14 '25 |
Buy |
12.79 |
100,000 |
1,279,040 |
735,993 |
| SCULLY WILLIAM P | 10% Owner |
Dec 18 '24 |
Buy |
13.93 |
73,436 |
1,022,670 |
1,297,693 |
| SCULLY WILLIAM P | 10% Owner |
Dec 31 '24 |
Buy |
13.01 |
32,000 |
416,393 |
650,193 |
| SCULLY WILLIAM P | 10% Owner |
Dec 20 '24 |
Buy |
15.91 |
2,000 |
31,813 |
618,693 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):